Similar results have been found in adjuvant-induced arthritis (AA) and collagen-induced arthritis (CIA) rodent models, which were achieved via modulating the migration of T cells and DCs, as well as regulating T cell polarization (220–222), suggesting that S1PR1-deletion could be a pharmacological strategy for RA. Here, S1PR1 is linked to rheumatoid arthritis.